Compounding of Hazardous Medications with QuartetRx®

The USP 800 Guidelines have made the compounding of liquid formulations of NIOSH list medications more cumbersome and costly. Many institutions have updated facilities, revised standard operating procedures, and trained staff at much expense in order to continue to offer this service to their patients. For some, the high costs […]

Read More…

Neonatal Clonidine Formulation

Through P&C’s collaboration with Akron Children’s Hospital in Ohio, a new neonatal clonidine formulation has been created using QuartetRx®. The formulation employs 0.3 mg clonidine tablets in water and simple syrup yielding a final concentration of 20 mcg/ml. Formulation and stability data presented at the 2019 ASHP Midyear meeting in […]

Read More…